Exabis Library
Welcome to the e-CCO Library!
DOP64: Minimal additional benefits in adding fecal hemoglobin to fecal calprotectin in predicting endoscopic disease activity in patients with inflammatory bowel disease
2019
ECCO'19 Copenhagen
Tuesday, 28 May 2019, 3:32 PM
1
DOP64: Pathogenic RIPK1 Mutations Cause Infantile-onset IBD with Inflammatory and Fistulizing Features
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
DOP64: Steroid-sparing effect of risankizumab vs ustekinumab in patients with moderately to severely active Crohn’s Disease: Post hoc results from the phase 3b SEQUENCE trial
2024
ECCO'24 Stockholm
Tuesday, 30 April 2024, 5:03 PM
DOP64: Utilising genomics to predict outcomes and delineate novel subgroups in inflammatory bowel disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 2:22 PM
DOP64: Utilising genomics to predict outcomes and delineate novel subgroups in inflammatory bowel disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
DOP65 Mirikizumab regulates genes involved in anti-TNF resistance and ulcerative colitis disease activity
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
DOP65: Development and validation of the TUMMY-UC, a patient-reported outcome in pediatric Ulcerative Colitis: A multicenter prospective study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
DOP65: Dietary therapy with the Crohn’s Disease exclusion diet induces sustained clinical and endoscopic remission in adults with Mild to Moderate Crohn's Disease: Results from the CDED-AD trial
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
DOP65: Infliximab plus azathioprine and quick steroids discontinuation versus azathioprine plus steroids in patients with acute severe Ulcerative Colitis responding to intravenous steroids: a parallel, open-label randomized controlled trial
2024
ECCO'24 Stockholm
Tuesday, 30 April 2024, 5:03 PM
DOP65: T-cell derived TGFβ1 remodels the rectum mesenchyme in Crohn's Disease patients with perianal fistulizing disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
DOP65: T-cell derived TGFβ1 remodels the rectum mesenchyme in Crohn’s Disease patients with perianal fistulizing disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 2:22 PM
DOP65: The association of faecal calprotectin level and combined mucosal and transmural healing in patients with Crohn’s disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
DOP65: The association of fecal calprotectin level and combined mucosal and transmural healing in patients with Crohn's disease
2019
ECCO'19 Copenhagen
Tuesday, 28 May 2019, 3:32 PM
1
DOP66 A CEACAM5 small peptide restores the suppressive activity of CD8 + T cells in patients with Crohn’s disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
DOP66: Disease course of Ulcerative proctitis in children: A population based study on behalf of the SIGENP IBD Group
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
DOP66: Ileal resections from fibrotic-CD patients present microbiota dysbiosis, altered metabolomic profiles and metabolite-sensing GPCRs expression
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 2:22 PM
DOP66: Ileal resections from fibrotic-CD patients present microbiota dysbiosis, altered metabolomic profiles and metabolite-sensing GPCRs expression
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
DOP66: INSPIRE: Preliminary data from an observational post-marketing registry on the effectiveness and safety of darvadstrocel in patients with Crohn’s Disease and complex perianal fistulas
2024
ECCO'24 Stockholm
Tuesday, 30 April 2024, 5:03 PM
DOP66: Surveillance colonoscopies in ulcerative colitis: does it make a difference?
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
DOP66: Surveillance colonoscopies in Ulcerative Colitis: Does it make a difference?
2019
ECCO'19 Copenhagen
Tuesday, 28 May 2019, 3:32 PM
1